Cancer Care Resilience Program

The COVID-19 pandemic has had a drastic impact on the timely delivery of a wide range of healthcare services. The pandemic has resulted in heightened fear and anxiety amongst individuals with cancer as screening, treatment, and surgeries have been delayed due to the risks of contracting the virus and the focus on ensuring hospitals were prepared for a possible influx of infected patients. The goal of the COVID-19 and Cancer Program (previously, the McGill Task Force on the Impact of COVID-19 on Cancer Control and Care) was to prepare a contingency plan to mitigate risks for individuals with cancer in the McGill health network. Data (previous years to the present day) focusing on various aspects of cancer-related services across the network will be collected to determine which activities associated with cancer screening and care have been suppressed or altered due to the pandemic. These findings will inform decisions on setting priorities and timelines as well as developing strategies for resumption and improvement of cancer-related services across the network.

A review of the literature and an environmental scan of national and international professional guidelines have been conducted to assess the global impact of the pandemic on cancer screening, prevention and care: A Review of Canadian Cancer-Related Clinical Practice Guidelines and Resources during the COVID-19 Pandemic. Eliya Farah, Rami Ali, Parker Tope, Mariam El-Zein, Eduardo L Franco, McGill Task Force On Covid-And Cancer.  Current Oncology, 2021 Feb 25;28(2):1020-1033.

Epidemiologic modelling for the most common types of cancer has been done to estimate the impact of the pandemic on cancer incidence and cancer survival due to delays in diagnosis, deferred screening and altered or suspended treatments. This can inform evidence-based decisions to assist the resumption of specific diagnostic and treatment processes: Predicted long-term impact of COVID-19 pandemic-related care delays on cancer mortality in Canada. Talía Malagón, Jean H E Yong, Parker Tope, Wilson H Miller Jr, Eduardo L Franco, McGill Task Force on the Impact of COVID-19 on Cancer Control and Care. Int J Cancer. 2022 Apr 15;150(8):1244-1254. doi: 10.1002/ijc.33884. Epub 2021 Dec 3.

In the fall of 2023 the COVID-19 and Cancer Program was re-named the Cancer Care Resilience Program.

Program Core Group

Sarah Botting-Provost
Mariam El-Zein
Eduardo Franco  
Caroline Lambert
Talia Malagón
Wilson Miller
Samantha Morais
Callum Mullen
Luca Petruccelli
Gayle Shinder
Parker Tope
Emma Wallens
Yi-Chuan Yu

Program Members Serving an Advisory Role

(Contributing expertise and experience in all subspecialties of oncology as well as surgery, nursing, psychology, palliative care, microbiology & immunology, obstetrics & gynecology, health economics, and epidemiology)

Jason Agulnik
Armen Aprikian
Jamil Asselah
Sarit Assouline
Nicole Basta
Hitesh Bhanabhai
Gerald Batist
Christine Bouchard
Matthew Cheng
Fabio Cury
Sinziana Dumitra
Arielle Elkrief
Melissa Henry
Antonis Koromilas
Susie Lau
Chen Liang
Carmen Loiselle
Antoine Loutfi
Christine Maheu
Ari Meguerditchian
Sarkis Meterissian
Michael Pollak
Jean-Pierre Routy
Shannon Salvador
Donald Sheppard
Jonathan Spicer
Erin Strumpf
Stephanie Wong

Contact

Program Director

Wilson Miller
Professor
Gerald Bronfman Department of Oncology
 

Coordinator

gayle.shinder [at] mcgill.ca (Gayle Shinder)
Chair's Senior Advisor for Academic Programs
Gerald Bronfman Department of Oncology
Tel: 514-398-8466

Back to top